The company will market the system to the private and public sector of these regions.
"The partnership with CTLM paves the ground to pursue the broader social objectives such as the massive extension of the screening programs to the women under age 49. We will pursue this with the full involvement of the radiologists by utilizing the CTLM systems currently installed and collaborating with present users," stated Giulio Ottavio, Battagliarin CEO of Socrate Medical SRL. "We want to contribute to reaching the goal of reducing the mortality rate among women by adding the latest technical advancements of breast cancer detection devices to the medical community," continued Giulio Ottavio Battagliarin, CEO of Socrate Medical SRL.
Based in Milan and established in 2003, Socrate Medical strives to distribute and market the latest and most advanced diagnostic imaging technologies while serving as a single point of contact to meet clients' specific requirements. Socrate Medical has been a forerunner in the identification and proposal of non radiant solutions suitable for targeted early diagnosis in women aged between 20 and 49. This has been done in collaboration with prestigious institutions, such as the Macchi Foundation of Varese, the Zucchi Hospital in Monza and the IPA in Rome, where 5,000 women will be screened each year. Socrate Medical has proposed solutions involving breast cancer detection equipment coupled with advance ultrasound scanners.
"We are pleased to have Socrate Medical as our representative in North and Central Italy, which have been important markets for IDSI," stated IDSI Senior Vice President Deborah O'Brien. "The enthusiasm and interest that this emerging company is capable of generating could be significant."
((Comments on this story may be sent to newsdesk@closeupmedia.com))

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index